Advertisement
Screener

DAVITA INC. (DVA) Payments to Acquire Other Investments

2.0 / 5 stars · 43/110 Roast Me

DAVITA INC. Payments to Acquire Other Investments

DAVITA INC. (DVA) reported Payments to Acquire Other Investments of $12.87 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireOtherInvestments · last filed 2026-08-04

  • DAVITA INC. payments to acquire other investments for the quarter ending 2026-06-30 was $3.21M, a 504.90% increase year-over-year.
  • DAVITA INC. payments to acquire other investments for the quarter ending 2026-03-31 was $9.65M, a 290.73% increase year-over-year.
  • DAVITA INC. payments to acquire other investments for the quarter ending 2025-09-30 was $350.00K, a 93.49% decline year-over-year.
  • DAVITA INC. payments to acquire other investments for the quarter ending 2025-06-30 was $531.00K, a 21.79% increase year-over-year.
  • DAVITA INC. payments to acquire other investments for fiscal 2024 was $0.00.
  • DAVITA INC. payments to acquire other investments for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
  • DAVITA INC. payments to acquire other investments for fiscal 2022 was $782.00K, a 4.97% increase from fiscal 2021.
  • DAVITA INC. payments to acquire other investments for fiscal 2021 was $745.00K.
Period endPayments to Acquire Other Investments 3 monthPayments to Acquire Other Investments 6 monthPayments to Acquire Other Investments 9 monthPayments to Acquire Other Investments 12 month
2026-06-30$3.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$12.87M
10-Q · filed 2026-08-04
2026-03-31$9.65M
10-Q · filed 2026-05-05
2025-09-30$350.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
$881.00K
derived: sum of 2 quarters · filed 2026-08-04
$3.35M
10-Q · filed 2025-10-29
-$5.43M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30$531.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$3.00M
10-Q · filed 2026-08-04
-$5.78M
derived: sum of 3 quarters · filed 2026-08-04
-$409.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$2.47M
10-Q · filed 2026-05-05
-$6.31M
derived: sum of 2 quarters · filed 2026-05-05
-$940.00K
derived: sum of 3 quarters · filed 2026-05-05
-$504.00K
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31-$8.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
-$3.41M
derived: sum of 2 quarters · filed 2025-10-29
-$2.98M
derived: sum of 3 quarters · filed 2025-10-29
$0.00
10-K · filed 2025-02-13
2024-09-30$5.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
$5.81M
derived: sum of 2 quarters · filed 2025-10-29
$8.78M
10-Q · filed 2025-10-29
$2.09M
derived: sum of 4 quarters · filed 2025-10-29
2024-06-30$436.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$3.41M
10-Q · filed 2025-08-05
-$3.28M
derived: sum of 3 quarters · filed 2025-08-05
-$2.96M
derived: sum of 4 quarters · filed 2025-08-05
2024-03-31$2.98M
10-Q · filed 2025-05-12
-$3.72M
derived: sum of 2 quarters · filed 2025-05-12
-$3.39M
derived: sum of 3 quarters · filed 2025-05-12
-$1.67M
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31-$6.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
-$6.37M
derived: sum of 2 quarters · filed 2025-02-13
-$4.64M
derived: sum of 3 quarters · filed 2025-02-13
$0.00
10-K · filed 2025-02-13
2023-09-30$327.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29
$2.05M
derived: sum of 2 quarters · filed 2024-10-29
$6.69M
10-Q · filed 2024-10-29
$4.15M
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30$1.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$6.37M
10-Q · filed 2024-08-06
$3.83M
derived: sum of 3 quarters · filed 2025-02-13
$4.14M
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31$4.64M
10-Q · filed 2024-05-02
$2.10M
derived: sum of 2 quarters · filed 2025-02-13
$2.42M
derived: sum of 3 quarters · filed 2025-02-13
$2.70M
derived: sum of 4 quarters · filed 2025-02-13
2022-12-31-$2.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
-$2.23M
derived: sum of 2 quarters · filed 2025-02-13
-$1.94M
derived: sum of 3 quarters · filed 2025-02-13
$782.00K
10-K · filed 2025-02-13
2022-09-30$312.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$596.00K
derived: sum of 2 quarters · filed 2023-11-07
$3.32M
10-Q · filed 2023-11-07
$1.46M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-30$284.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$3.01M
10-Q · filed 2023-08-03
$1.15M
derived: sum of 3 quarters · filed 2024-02-14
$1.59M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-31$2.73M
10-Q · filed 2023-05-08
$862.00K
derived: sum of 2 quarters · filed 2024-02-14
$1.31M
derived: sum of 3 quarters · filed 2024-02-14
$1.69M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-31-$1.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
-$1.42M
derived: sum of 2 quarters · filed 2024-02-14
-$1.03M
derived: sum of 3 quarters · filed 2024-02-14
$745.00K
10-K · filed 2024-02-14
2021-09-30$445.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-31
$830.00K
derived: sum of 2 quarters · filed 2022-10-31
$2.61M
10-Q · filed 2022-10-31
-$779.00K
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30$385.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01
$2.16M
10-Q · filed 2022-08-01
-$1.22M
derived: sum of 3 quarters · filed 2023-02-22
2021-03-31$1.78M
10-Q · filed 2022-05-05
-$1.61M
derived: sum of 2 quarters · filed 2023-02-22
2020-12-31-$3.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$0.00
10-K · filed 2023-02-22
2020-09-30$3.39M
10-Q · filed 2021-10-28
2019-12-31$0.00
10-K · filed 2022-02-11
2009-12-31$6.30M
10-K · filed 2011-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sotera Health Co (SHC)United States$5.271B30.96
Progyny, Inc. (PGNY)United States$1.994B28.37
agilon health, inc. (AGL)United States$1.272B-7.76
VIEMED HEALTHCARE, INC. (VMD)United States$0.336B29.92
Park Dental Partners, Inc. (PARK)United States$0.094B
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
CRYO CELL INTERNATIONAL INC (CCEL)United States$0.033B-11.02
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43